0001225208-12-017361.txt : 20120807
0001225208-12-017361.hdr.sgml : 20120807
20120807160953
ACCESSION NUMBER: 0001225208-12-017361
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120807
FILED AS OF DATE: 20120807
DATE AS OF CHANGE: 20120807
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Clemmer James C
CENTRAL INDEX KEY: 0001476700
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33259
FILM NUMBER: 121013339
MAIL ADDRESS:
STREET 1: COVIDIEN PLC
STREET 2: 15 HAMPSHIRE STREET
CITY: MANSFIELD
STATE: MA
ZIP: 02048
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Covidien plc
CENTRAL INDEX KEY: 0001385187
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 980624794
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 20 ON HATCH
STREET 2: LOWER HATCH STREET
CITY: DUBLIN
STATE: L2
ZIP: DUBLIN 2
BUSINESS PHONE: 353 1 438-1700
MAIL ADDRESS:
STREET 1: 20 ON HATCH
STREET 2: LOWER HATCH STREET
CITY: DUBLIN
STATE: L2
ZIP: DUBLIN 2
FORMER COMPANY:
FORMER CONFORMED NAME: Covidien Ltd.
DATE OF NAME CHANGE: 20070321
FORMER COMPANY:
FORMER CONFORMED NAME: Tyco Healthcare Ltd.
DATE OF NAME CHANGE: 20070104
4
1
doc4.xml
X0306
4
2012-08-07
0001385187
Covidien plc
COV
0001476700
Clemmer James C
C/O COVIDIEN
15 HAMPSHIRE STREET
MANSFIELD
MA
02048
1
Senior Vice President
Ordinary Shares
2012-08-07
4
M
0
36000.0000
43.0878
A
66379.0000
D
Ordinary Shares
2012-08-07
4
M
0
26106.0000
38.6485
A
92485.0000
D
Ordinary Shares
2012-08-07
4
M
0
22717.0000
34.1500
A
115202.0000
D
Ordinary Shares
2012-08-07
4
S
0
84823.0000
57.3029
D
30379.0000
D
Stock Option (Right to Buy)
43.0878
2012-08-07
4
M
0
36000.0000
0.0000
D
2017-07-01
Ordinary Shares
36000.0000
0.0000
D
Stock Option (Right to Buy)
38.6485
2012-08-07
4
M
0
26106.0000
0.0000
D
2016-11-20
Ordinary Shares
26106.0000
0.0000
D
Stock Option (Right to Buy)
34.1500
2012-08-07
4
M
0
22717.0000
0.0000
D
2018-11-30
Ordinary Shares
22717.0000
7573.0000
D
The price reported is the weighted average price. Shares were sold in multiple transactions at prices ranging from $57.30 to $57.36. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a securityholder of the Issuer, full information regarding the number of shares sold at each price.
Fully exercisable.
Options become exercisable in equal installments on each of the first, second, third and fourth anniversary of the grant date.
By: John W. Kapples, Attorney in Fact
2012-08-07